Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. 1989

D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
University of Southern California Medical School.

Fifty-five patients completed a 5-week double-blind study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. There was no concomitant behavioral treatment. Patient and therapist rating scales included Sheehan's Panic and Anxiety Attack Scales, the Marks-Sheehan Phobia Scale, the Hamilton Anxiety Scale, the Hamilton Depression Scale, and the Side Effects Checklist. The results generally support the efficacy of alprazolam, but not propranolol, in the treatment of panic disorder and agoraphobia with panic attacks. The significance of the results are discussed, as well as a number of the unique aspects of our procedures and patient population.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010200 Panic A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function. Panics
D010698 Phobic Disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable. Claustrophobia,Neuroses, Phobic,Phobia, School,Phobias,Phobic Neuroses,Scolionophobia,Disorder, Phobic,Phobia,Phobic Disorder,School Phobia
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011581 Psychological Tests Standardized tests designed to measure abilities (as in intelligence, aptitude, and achievement tests) or to evaluate personality traits. Parenting Stress Index,Trier Social Stress Test,Trier Stress Test,Psychologic Tests,Psychological Test,Test, Psychological,Tests, Psychological,Index, Parenting Stress,Psychologic Test,Stress Index, Parenting,Stress Test, Trier,Test, Psychologic,Test, Trier Stress,Trier Stress Tests
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005239 Fear The affective response to an actual current external danger which subsides with the elimination of the threatening condition. Threat Cues,Threat Sensitivity,Cue, Threat,Fears,Sensitivity, Threat,Threat Cue,Threat Sensitivities
D005260 Female Females

Related Publications

D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
October 1984, Texas medicine,
D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
July 1984, The American journal of psychiatry,
D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
June 1987, The American journal of psychiatry,
D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
May 1991, Biological psychiatry,
D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
November 1992, The American journal of psychiatry,
D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
January 1985, Comprehensive psychiatry,
D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
January 1993, Comprehensive psychiatry,
D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
March 1985, The Psychiatric clinics of North America,
D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
December 1986, The American journal of psychiatry,
D J Munjack, and B Crocker, and D Cabe, and R Brown, and R Usigli, and A Zulueta, and M McManus, and D McDowell, and R Palmer, and M Leonard
August 1988, The Journal of clinical psychiatry,
Copied contents to your clipboard!